Jordan vs Maldives: Tuberculosis patients living with HIV receiving antiretroviral therapy
Jordan
0 patients
in 2021
Maldives
0 patients
in 2021
Jordan rank
141st
Maldives rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Jordan
- Maldives
How they compare
Jordan currently reports 0 patients against 0 patients in Maldives, a difference of 0 patients.
The two have swapped places 4 times across 14 shared years of data; in 2008 it was Maldives ahead.
Jordan ranks 141st and Maldives ranks 141st of 183 countries.
Jordan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jordan | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0 patients | 0 patients | — |
| 2010s | 0.5 patients | 0.2 patients | 0.3 patients | Jordan |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Jordan or Maldives?
- Jordan, at 0 patients against 0 patients in Maldives as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Jordan and Maldives?
- 0 patients, with Jordan ahead.
- How many years of comparable data are there for Jordan and Maldives?
- 14 years are reported by both, from 2008 to 2021.
- How do Jordan and Maldives rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Jordan ranks 141st and Maldives ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.